HARVARD BIOSCIENCE INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Harvard Bioscience Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Harvard Bioscience Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $597K, a 8.58% decline year-over-year.
  • Harvard Bioscience Inc annual Operating Lease, Payments for 2023 was $2.37M, a 0.85% increase from 2022.
  • Harvard Bioscience Inc annual Operating Lease, Payments for 2022 was $2.35M, a 0.76% decline from 2021.
  • Harvard Bioscience Inc annual Operating Lease, Payments for 2021 was $2.37M, a 13% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $597K -$56K -8.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $653K +$59K +9.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $594K -$17K -2.78% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q1 2021 $611K -$76K -11.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.52M $687K -$15K -2.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $2.53M -$1.35M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-03-17
Q3 2019 $1.82M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.37M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $702K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.